Pfizer Inc (PFE) $22.73 +1.77%
Pfizer (PFE) is up 38 cents to $22.71 and perhaps getting a lift from today’s 4.1 percent rally in Merck (MRK), which is up on drug trial news and a Citigroup upgrade. Recent options trades on Pfizer include a Dec 20 – 24 risk-reversal at 4 cents, 27300X on ISE. The investor sold puts to buy calls, 32000X total, and is opening a new position, according to ISEE. The bullish combo is being intiated ahead of Pfizer’s July 31 earnings report.
Category: All Stocks, Large Cap Stocks, Pharmaceuticals & Biotechnology
Free Newsletter
If you enjoyed this article, sign up to receive more just like it.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.
